Pharvaris Ownership

PHVS Stock

USD 22.36 1.81 7.49%

Pharvaris owns a total of 54.23 Million outstanding shares. The majority of Pharvaris BV outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Pharvaris BV to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Pharvaris. Please pay attention to any change in the institutional holdings of Pharvaris BV as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Shares in Circulation

First Issued

2018-03-31

Previous Quarter

53.9 M

Current Value

54.2 M

Avarage Shares Outstanding

34.3 M

Quarterly Volatility

10.5 M

Covid

Some institutional investors establish a significant position in stocks such as Pharvaris in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Pharvaris, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Dividend Paid And Capex Coverage Ratio is likely to drop to -1,086 in 2024. Common Stock Shares Outstanding is likely to drop to about 31.4 M in 2024. Net Loss is likely to gain to about (65.3 M) in 2024.

Market Cap Enterprise Value

Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharvaris BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

Pharvaris Stock Ownership Analysis

About 88.0% of the company shares are owned by institutional investors. The book value of Pharvaris was at this time reported as 7.35. The company recorded a loss per share of 2.72. Pharvaris BV had not issued any dividends in recent years. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company was incorporated in 2015 and is based in Leiden, the Netherlands. Pharvaris is traded on NASDAQ Exchange in the United States. To find out more about Pharvaris BV contact CPA MBA at 31 71 203 6410 or learn more at https://pharvaris.com.

Besides selling stocks to institutional investors, Pharvaris also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Pharvaris' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Pharvaris' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Pharvaris Quarterly Liabilities And Stockholders Equity

313.18 Million

About 9.0% of Pharvaris BV are currently held by insiders. Unlike Pharvaris' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Pharvaris' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Pharvaris' insider trades

Pharvaris Outstanding Bonds

Pharvaris issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pharvaris BV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pharvaris bonds can be classified according to their maturity, which is the date when Pharvaris BV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Dana 575 percent Corp Bond US235822AB96	View
	Volcan Compania Minera Corp Bond USP98047AC08	View
	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MPLX LP 4875 Corp Bond US55336VAG59	View
	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	International Game Technology Corp Bond US460599AD57	View

View All Pharvaris Corporate Bonds

Pharvaris Corporate Filings

6K	13th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.	View Verify
	12th of April 2024 Other Reports	View Verify
13A	14th of February 2024 An amended filing to the original Schedule 13G	View Verify

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Pharvaris Stock Analysis

When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC